A Network Pharmacology-Based Approach to Investigate the Novel TCM Formula against Huntington’s Disease and Validated by Support Vector Machine Model

Table 6

Candidate compounds screened out in this trial for CK2A2 and mtHSP70 protein.

Compound name	DOCK SCORE	SVM		MLR		Consensus		Total Score
		pIC	Vote	pIC	Vote	CS	Vote
		50		50
Miraxanthin
III	114.346	7.08	0	8.45	1	4	1	2
Flazine	96.004	7.98	1	4.63	0	4	1	2
Typhic acid	97.811	7.08	0	5.01	0	7	1	1
7FC(control)	108.017	7.06	0	6.52	1	7	1	2
Tetrahydrodeox
-yoxolucidine A	119.845	6.88	1	6.10	1	3	1	3
Febrifugine	107.889	6.87	1	6.93	1	3	1	3
Holantosine C	162.286	6.86	1	6.45	1	2	0	2
Cassaine	109.044	6.86	1	7.39	1	2	0	2